David Evendon-Challis

David Evendon-Challis is the Chief Scientific Officer, Consumer Health & Executive Board Member at Bayer. Prior to this, they were the VP - Health Innovation & Emerging Science at RB from August 2011 to December 2019. David was responsible for innovation across RB's health business, with a special focus on disruptive and digital product innovation, creation of new brands, external partnerships, consumer-centric innovation and scientific and partner engagement. From February 2011 to August 2011, they were the Head of Consultancy at Salterbaxter. David then became the Associate Director at MHP Communications from August 2009 to March 2011. Prior to that, they were the Head of Sustainability & Public Affairs EMEA at Kimberly-Clark from January 2002 to September 2009.

David Evendon-Challis has a Master of Arts in Biological Sciences from the University of Oxford, a NEBOSH National General Certificate in Occupational Safety & Health from NEBOSH, and a CIPR Advanced Certificate in Public Relations from Birkbeck, University of London. David also has certification from Melcrum as a Black Belt in Internal Communication, Social Accountability International as an SA8000 Lead Auditor, and BSI as an ISO 14001 Lead Auditor.

David Evendon-Challis reports to Heiko Schipper, President, Consumer Health. David Evendon-Challis works with Oliver Rittgen - CFO, Consumer Health, John Koelink - COO, Consumer Health, and Patricia Corsi - Global Chief Marketing & Digital Officer, Consumer Health.